PDS Biotechnology Corp. (PDSB)
0.2947
-0.01
(-1.77%)
USD |
NASDAQ |
Sep 09, 12:20
PDS Biotechnology Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2026 | 12.89 |
| June 26, 2026 | 12.74 |
| June 25, 2026 | 12.82 |
| June 24, 2026 | 12.53 |
| June 23, 2026 | 13.08 |
| June 22, 2026 | 13.50 |
| June 18, 2026 | 13.69 |
| June 17, 2026 | 13.03 |
| June 16, 2026 | 13.77 |
| June 15, 2026 | 14.63 |
| June 12, 2026 | 15.06 |
| June 11, 2026 | 16.06 |
| June 10, 2026 | 15.20 |
| June 09, 2026 | 14.77 |
| June 08, 2026 | 14.34 |
| June 05, 2026 | 14.63 |
| June 04, 2026 | 17.49 |
| June 03, 2026 | 15.49 |
| June 02, 2026 | 16.63 |
| June 01, 2026 | 16.35 |
| May 29, 2026 | 15.49 |
| May 28, 2026 | 15.34 |
| May 27, 2026 | 15.92 |
| May 26, 2026 | 15.77 |
| May 22, 2026 | 17.21 |
| Date | Value |
|---|---|
| May 21, 2026 | 16.63 |
| May 20, 2026 | 14.77 |
| May 19, 2026 | 14.34 |
| May 18, 2026 | 16.92 |
| May 15, 2026 | 19.21 |
| May 14, 2026 | 20.50 |
| May 13, 2026 | 19.07 |
| May 12, 2026 | 15.77 |
| May 11, 2026 | 18.64 |
| May 08, 2026 | 17.92 |
| May 07, 2026 | 16.35 |
| May 06, 2026 | 15.20 |
| May 05, 2026 | 15.20 |
| May 04, 2026 | 14.34 |
| May 01, 2026 | 14.06 |
| April 30, 2026 | 13.95 |
| April 29, 2026 | 13.77 |
| April 28, 2026 | 15.49 |
| April 27, 2026 | 13.34 |
| April 24, 2026 | 12.91 |
| April 23, 2026 | 13.31 |
| April 22, 2026 | 18.50 |
| April 21, 2026 | 19.21 |
| April 20, 2026 | 18.50 |
| April 17, 2026 | 18.78 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.656 |
| Alnylam Pharmaceuticals, Inc. | 25.22 |
| Anika Therapeutics, Inc. | 2.043 |
| Savara, Inc. | 7.692 |
| Vericel Corp. | 5.367 |
Price to Book Value Related Metrics
| Price | 0.2947 |
| Earnings Yield | -217.3% |
| Market Cap | 16.48M |